NCT01672931

Brief Summary

We believe that there is an association between BMI and oocyte diameter in women undergoing IVF treatments. We plan to measure the oocyte diameter in 2 groups of women undergoing IVF. One group will have BMI 20-25 and the other group will have BMI above 30.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 27, 2012

Completed
5 days until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
Last Updated

August 27, 2012

Status Verified

August 1, 2012

Enrollment Period

1 year

First QC Date

August 22, 2012

Last Update Submit

August 22, 2012

Conditions

InfertilityObesity

Outcome Measures

Primary Outcomes (1)

  • Larger Size of Oocyte Diameter

    Oocyte will be measured in women undergoing IVF treatment

    One year

Study Arms (2)

BMI over 30

Women undergoing IVF with BMI over 30

Other: Oocyte Measurement

BMI 20-25

Women undergoing IVF treatments with BMI between 20-25

Other: Oocyte Measurement

Interventions

Oocyte MeasurementOTHER
BMI 20-25BMI over 30

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Women undergoing IVF treatments

You may qualify if:

  • IVF treated patients
  • BMI between 20-25 or over 30

You may not qualify if:

  • Everyone else

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hillel Yaffe Medical Center

Hadera, 38100, Israel

Location

Related Publications (1)

  • Atzmon Y, Shoshan-Karchovsky E, Michaeli M, Aslih N, Shrem G, Ellenbogen A, Shalom-Paz E. Obesity results with smaller oocyte in in vitro fertilization/intracytoplasmic sperm injection cycles-a prospective study. J Assist Reprod Genet. 2017 Sep;34(9):1145-1151. doi: 10.1007/s10815-017-0975-6. Epub 2017 Jun 17.

    PMID: 28624860DERIVED

MeSH Terms

Conditions

InfertilityObesity

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Gai Shrem, MD

    Hillel Yaffe Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gai Shrem, MD

CONTACT

972-50-6793080gai.shrem@gmail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2012

First Posted

August 27, 2012

Study Start

September 1, 2012

Primary Completion

September 1, 2013

Study Completion

September 1, 2013

Last Updated

August 27, 2012

Record last verified: 2012-08

Locations

IL(1)